focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan American Regulatory News (JAM)

Share Price Information for JPMorgan American (JAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 987.00
Bid: 987.00
Ask: 990.00
Change: 5.00 (0.51%)
Spread: 3.00 (0.304%)
Open: 982.00
High: 989.00
Low: 982.00
Prev. Close: 982.00
JAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update Statement

15 Oct 2019 15:06

RNS Number : 9718P
JPMorgan American IT PLC
15 October 2019
 

STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN AMERICAN INVESTMENT TRUST PLC

 

UPDATE STATEMENT

 

Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with provision 1.D.4 of the 2018 UK Code of Corporate Governance and principle 5.2.4 of the 2019 AIC Code of Corporate Governance.

 

At the Company's AGM held on 2nd May 2019, the Company received the following votes in respect of resolution 14: to approve the Company's new Investment Policy:

 

Resolution

For

Against

Total Cast (excluding votes withheld)

Withheld

14. To approve the new Investment Policy

90,957,517

23,898,101

114,855,618

89,433

Percentage of votes cast

79.19%

20.81%

100.0%

-

Following the AGM, the Board was pleased to announce that shareholders approved the Company's new investment policy, which incorporated the changes required to move the Company's large-cap equity portfolio to a higher-conviction investment approach combining the best ideas from JPMorgan Asset Management's US growth and value investment teams. Furthermore on 5th June 2019, the Board announced that the Company's portfolio had been transitioned to a portfolio reflecting the new investment process.

Since the results of the AGM and in light of the votes against the resolution to approve the new investment policy, which equated to 20.81% of the total shares voted by proxy, the Board, via the Chair and the Manager's investor relations team has been in frequent dialogue with major shareholders, including recent meetings with the two key dissenting shareholders to address their concerns.

The Board continues to believe that the change in investment process is in the best interests of the Company and its shareholders. Shareholders are reminded that alongside the changes in investment process, the Board negotiated amendments to the fees paid to the Manager, through the removal of the performance fee element of the fee, and a short-term fee waiver through to the end of February 2020. The Manager is also bearing the transaction costs associated with the reorganisation of the portfolio to the new investment strategy.

Future steps

In light of the Company's meetings with shareholders since the AGM, the Board will not be taking any further specific action regarding this vote, other than to continue with its ongoing engagement with shareholders.

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Accounts which is available for viewing at the National Storage Mechanism which can be located at www.morningstar.co.uk/uk/NSM and on the Company's website, www.jpmamerican.co.uk.

A summary of the proxy votes received is also available on the Company's website, www.jpmamerican.co.uk.

 

15th October 2019

 

For further information, please contact:

 

Alison Vincent

For and on behalf of

JPMorgan Funds Limited - Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGMMMGDKZGLZM
Date   Source Headline
5th Sep 20233:58 pmRNSHolding(s) in Company
5th Sep 202310:55 amRNSNet Asset Value(s)
4th Sep 202312:35 pmRNSGearing Announcement
4th Sep 202312:20 pmRNSHolding(s) in Company
4th Sep 202310:40 amRNSNet Asset Value(s)
1st Sep 202312:50 pmRNSNet Asset Value(s)
31st Aug 202311:14 amRNSNet Asset Value(s)
30th Aug 202310:58 amRNSNet Asset Value(s)
29th Aug 20231:31 pmRNSGearing announcement
29th Aug 202312:26 pmRNSNet Asset Value(s)
25th Aug 202311:04 amRNSNet Asset Value(s)
24th Aug 202310:58 amRNSNet Asset Value(s)
23rd Aug 20233:41 pmRNSHolding(s) in Company
23rd Aug 202310:57 amRNSNet Asset Value(s)
22nd Aug 202310:41 amRNSNet Asset Value(s)
21st Aug 202312:28 pmRNSGearing Announcement
21st Aug 202310:30 amRNSNet Asset Value(s)
18th Aug 202310:43 amRNSNet Asset Value(s)
17th Aug 202311:02 amRNSNet Asset Value(s)
16th Aug 202311:07 amRNSNet Asset Value(s)
16th Aug 20239:34 amRNSTen Largest Investments
15th Aug 202311:48 amRNSNet Asset Value(s)
14th Aug 202312:08 pmRNSGearing Announcement
14th Aug 202310:44 amRNSNet Asset Value(s)
11th Aug 202310:58 amRNSNet Asset Value(s)
10th Aug 202310:38 amRNSNet Asset Value(s)
10th Aug 20237:05 amRNSDividend Declaration
10th Aug 20237:00 amRNSHalf-year Report
9th Aug 20233:17 pmRNSHolding(s) in Company
9th Aug 202311:19 amRNSNet Asset Value(s)
8th Aug 202310:46 amRNSNet Asset Value(s)
7th Aug 202312:03 pmRNSGearing announcement
7th Aug 202311:18 amRNSNet Asset Value(s)
4th Aug 202311:47 amRNSNet Asset Value(s)
3rd Aug 202311:13 amRNSNet Asset Value(s)
2nd Aug 202311:16 amRNSNet Asset Value(s)
1st Aug 202311:17 amRNSNet Asset Value(s)
1st Aug 202310:13 amRNSTotal Voting Rights
31st Jul 202312:25 pmRNSGearing Announcement
31st Jul 202311:52 amRNSNet Asset Value(s)
28th Jul 202311:19 amRNSNet Asset Value(s)
27th Jul 202310:29 amRNSNet Asset Value(s)
26th Jul 202310:39 amRNSNet Asset Value(s)
25th Jul 202310:52 amRNSNet Asset Value(s)
24th Jul 202312:23 pmRNSGearing Announcement
24th Jul 202310:36 amRNSNet Asset Value(s)
21st Jul 202310:34 amRNSNet Asset Value(s)
20th Jul 202311:06 amRNSNet Asset Value(s)
20th Jul 20237:00 amRNSKepler Trust Intelligence: New Research
19th Jul 202311:08 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.